Free Trial

NanoViricides (NNVC) News Today

$2.20
+0.08 (+3.77%)
(As of 05/21/2024 ET)
NanoViricides, Inc. (NNVC)
NanoViricides completes Phase 1 trial of lead asset NV-387
NanoViricides successfully concludes first-in-human study
Nanoviricides Inc NNVC
NanoViricides continues to progress antiviral drug candidate...
NNVC: NanoViricides Begins Clinical Trial of NV-CoV-2
NanoViricides progressing well with new Covid study
Why Are NanoViricides Shares Gaining Today
Get NanoViricides News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.

Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some

NNVC Media Mentions By Week

NNVC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NNVC
News Sentiment

0.32

0.44

Average
Medical
News Sentiment

NNVC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NNVC Articles
This Week

7

1

NNVC Articles
Average Week

Get NanoViricides News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:NNVC) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners